Quotables
"The radio craze will die out in time."
Thomas Edison ; 1922
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6596732 | 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same The invention relates to compounds of formula: ##STR1## and their solvates and/or hydrates exhibiting an affinity and a selectivity for arginine-vasopressin V1b receptors or for both V1b and V1a receptors.... | 07/22/2003 |
| 6586456 | Aminothiazole derivatives and their use as CRF receptor ligands Substituted 4-phenyl-2-aminothiazole derivatives, processes for preparing the same, and the use thereof as corticotropin releasing factor (CRF) antagonists.... | 07/01/2003 |
| 6573381 | Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates Methyl (R)-2-(R1 OSO2)-2-(2-chlorophenyl)acetates useful as intermediates in the preparation of methyl (S)-2(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]-5-pyridyl)acetate .... | 06/03/2003 |
| 6541488 | Compositions for treating arterial thrombosis and a factor Xa inhibitor The invention relates to the use of direct or indirect selective inhibitors of factor Xa acting via antithrombin III, alone or in combination with one or more compounds with anti-platelet aggregation activity, for the preparation of medicines intended to ... | 04/01/2003 |
| 6534481 | Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same A synthetic polysaccharide including an antithrombin III binding domain consisting of a concatenation of five monosaccharides supporting a total of two carboxylic acid functions and at least four sulpho groups, said domain being directly bound at the non-... | 03/18/2003 |
| 6528497 | Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same Novel synthetic polysaccharides for use in the treatment of pathologies associated with a coagulation dysfunction.... | 03/04/2003 |
| 6514531 | Controlled-release dosage forms comprising zolpidem or a salt thereof The present invention relates to controlled-release dosage forms of zolpidem or salts thereof adapted to release zolpidem over a predetermined time period, according to a biphasic profile of dissolution, where the first phase is an immediate release phase... | 02/04/2003 |
| 6509351 | Phenyl- and pyridyl-tetrahydro-pyridines having TNF inhibiting activity The present invention relates to compounds of formula (I): ##STR1## as well as the salts or solvates thereof, to pharmaceutical compositions containing them, to a process for preparing them and to synthetic intermediates in this process.... | 01/21/2003 |
| 6506750 | Morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives N-(phenylacetyl)morpholine derivatives useful as NK1 receptor antagonists, a process for the preparation thereof, and pharmaceutical compositions containing them as active principle.... | 01/14/2003 |
| 6504030 | Polymorphic form of clopidogrel hydrogen sulphate Novel orthorombic polymorph of clopidogrel hydrogen sulfate or hydrogen sulfate of methyl (+)-(S)--(2-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-5 -acetate and a process for its preparation... | 01/07/2003 |
| 6489334 | Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms The invention relates to a method of crystallizing a tetrahydropyridine derivative, to the novel crystalline forms thereby obtained and to the pharmaceutical compositions containing said tetrahydropyridine derivative in a given crystalline form as the act... | 12/03/2002 |
| 6465489 | Ureidopiperidine derivatives as selective human NK3 receptor antagonists The invention concerns compounds of formula (I) in racemic or optically pure form, methods for obtaining them and pharmaceutical compositions containing same. Said compounds are selective NK3 receptor antagonists. ##STR1##... | 10/15/2002 |
| 6451795 | 4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives, preparation and therapeutic use 4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives having affinity for the peripheral benzodiazepine receptors are useful for the prevention or treatment of peripheral neuropathies and for the treatment of central neurogenerative disea... | 09/17/2002 |
| 6429210 | Polymorphic clopidogrel hydrogenesulphate form Novel orthorombic polymorph of clopidogrel hydrogen sulfate or hydrogen sulfate of methyl (+)-(S)--(2-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-5 -acetate and a process for its preparation.... | 08/06/2002 |
| 6413984 | 8-(heterocyclylmethyl)quinoline derivatives for treating urinary incontinence The invention concerns compounds of formula (I) wherein: A represents either a hydrogen atom or a hydroxyl group; B represents a pyrrolidin-2-yl (D) or 2-piperidyl (E), B capable of being substituted by one or two R5 groups; R1 repre... | 07/02/2002 |
| 6395729 | Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors Pyridazino[4,5-b]indole-1-acetamide derivatives for the prevention or treatment of diseases linked to the dysfunctioning of peripheral-type benzodiazepine receptors.... | 05/28/2002 |
| 6362184 | 1, 2, 4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents A method of using 1,2,4-benzotriazine oxides, some of which are novel compounds, as radiosensitizers and selective cytotoxic agents is disclosed. These compounds are shown to specifically radiosensitive hypoxic tumor cells. Some are additionally disclosed... | 03/26/2002 |
| 6358965 | Use of benzoylalkyl-1,2,3,6-tetrahydropyridines The invention relates to the use of compounds of formula ##STR1## for the preparation of medicines designed for the treatment of neuronal and cerebral disorders. The invention also relates to the compounds of formula: ##STR2## a process for their preparat... | 03/19/2002 |
| 6344464 | Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination The invention relates to the use of tetrahydropyridine derivatives of the formula ##STR1## in which: R1 is a halogen or a CF3, (C1 -C4)alkyl or (C1 -C4)alkoxy group; Y is a nitrogen atom or... | 02/05/2002 |
| 6342505 | Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-댡 The invention relates to the use of a compound of formula (I): ##STR1## for the preparation of pharmaceutical compositions for increasing the circulating, cellular and extracellular levels of TGF-댡.... | 01/29/2002 |
| 6291672 | Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them Compounds of the formula ##STR1## are useful as human NK3 receptor antagonists.... | 09/18/2001 |
| 6284277 | Stable freeze-dried pharmaceutical formulation The subject of the invention is a freeze-dried formulation consisting of an amorphous phase and a crystalline phase, which is pharmaceutically acceptable, comprising at least one nonprotein active ingredient, characterized in that it contains mannitol and... | 09/04/2001 |
